Sfoglia per Autore
Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly
2019-01-01 Gatto, F.; Campana, C.; Cocchiara, F.; Corica, Giuliana; Albertelli, M.; Boschetti, M.; Zona, G.; Criminelli, D.; Giusti, M.; Ferone, D.
Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients
2019-01-01 Teti, C.; Talco, M.; Albertelli, M.; Albanese, V.; Minuto, M.; Aglialoro, A.; Monachesi, M.; Viviani, G.; Gatto, F.; Ferone, D.; Boschetti, M.
Aggressive and malignant prolactinomas
2019-01-01 Olarescu, Nicoleta; Perez-Rivas, Luis; Gatto, Federico; Cuny, Thomas; Tichomirowa, Maria; Tamagno, Gianluca; Gahete, Manuel
Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression
2019-01-01 Muhammad, Ammar; Coopmans, Eva. C.; Gatto, Federico; Franck, Sanne E.; Janssen, Joseph A. M. J. L.; Jan van der Lely, Aart; Hofland, Leo J.; Neggers, Sebastian J. C. M. M.
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells
2019-01-01 Gatto, Federico; Arvigo, Marica; Amaru', Jessica; Campana, Claudia; Cocchiara, Francesco; Graziani, Giulia; Bruzzone, Eleonora; Giusti, Massimo; Boschetti, Mara; Ferone, Diego
Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxide
2020-01-01 Sileo, F.; Cangiano, B.; Cacciatore, C.; Amaru, J.; Gatto, F.; Albertelli, M.; Falconi, M.; Vitale, G.; Persani, L.
Diagnosis and Treatment of Parasellar Lesions
2020-01-01 Gatto, F; Perez-Rivas, Lg; Olarescu, Nc; Khandeva, P; Chachlaki, K; Trivellin, G; Gahete, Md; Cuny, T.
Left ventricular mass reduction by a low-sodium diet in treated hypertensive patients
2020-01-01 Musso, N.; Gatto, F.; Nista, F.; Dotto, A.; Shen, Z.; Ferone, D.
Sodium Intake and Target Organ Damage in Hypertension-An Update about the Role of a Real Villain
2020-01-01 Nista, Federica; Gatto, Federico; Albertelli, Manuela; Musso, Natale
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study.
2020-01-01 Mazziotti, Gherardo; Battista, Claudia; Maffezzoni, Filippo; Chiloiro, Sabrina; Ferrante, Emanuele; Prencipe, Nunzia; Grasso, Ludovica; Gatto, Federico; Olivetti, Roberto; Arosio, Maura; Barale, Marco; Bianchi, Antonio; Cellini, Miriam; Chiodini, Iacopo; De Marinis, Laura; Del Sindaco, Giulia; Di Somma, Carolina; Ferlin, Alberto; Ghigo, Ezio; Giampietro, Antonella; Grottoli, Silvia; Lavezzi, Elisabetta; Mantovani, Giovanna; Morenghi, Emanuela; Pivonello, Rosario; Porcelli, Teresa; Procopio, Massimo; Pugliese, Flavia; Scillitani, Alfredo; Gerardo Lania, Andrea
Somatostatin receptor expression and patients' response to targeted medical treatment in pituitary tumors: evidences and controversies.
2020-01-01 Gatto, F; Arvigo, M; Ferone, D.
Emerging drugs for the treatment of acromegaly
2020-01-01 Campana, C.; Corica, G.; Nista, F.; Cocchiara, F.; Graziani, G.; Khorrami, K.; Franco, M.; Boschetti, M.; Ferone, D.; Gatto, F.
β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids
2020-01-01 Gatto, Federico; A Feelders, Richard; van der Pas, Rob; van Koetsveld, Peter; Bruzzone, Eleonora; Arvigo, Marica; Dogan, Fadime; Lamberts, Steven; Ferone, Diego; Hofland, L
Octreotide-resistant acromegaly: Challenges and solutions
2020-01-01 Corica, G.; Ceraudo, M.; Campana, C.; Nista, F.; Boschetti, M.; Zona, G.; Criminelli, D.; Ferone, D.; Gatto, F.
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients
2020-01-01 Paolino, S; Gotelli, E; Goegan, F; Casabella, A; Ferrari, G; Patane, M; Albertelli, M; Gatto, F; Pizzorni, C; Cattelan, F; Sulli, A; Smith, V; Cutolo, M
Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment
2021-01-01 Campana, C.; Cocchiara, F.; Corica, G.; Nista, F.; Arvigo, M.; Amaru, J.; Rossi, D. C.; Zona, G.; Ferone, D.; Gatto, F.
Acromegaly Management in a Tertiary Referral Center After 1 Year of the Coronavirus 2019 Pandemic: A Double Challenge
2021-01-01 Gatto, F.; Khorrami, K.; Nista, F.; Corica, G.; Ferone, D.
Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective
2021-01-01 Nista, F.; Corica, G.; Castelletti, L.; Khorrami, K.; Campana, C.; Cocchiara, F.; Zoppoli, G.; Prior, A.; Rossi, D. C.; Zona, G.; Ferone, D.; Gatto, F.
Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length
2021-01-01 Cocchiara, Francesco; Campana, Claudia; Nista, Federica; Corica, Giuliana; Ceraudo, Marco; Milioto, Angelo; Criminelli Rossi, Diego; Zona, Gianluigi; Ferone, Diego; Gatto, Federico
Octreotide and pasireotide combination treatment in somatotroph tumor cells: Predominant role of sst2 in mediating ligand effects
2021-01-01 Amaru, J.; Barbieri, F.; Arvigo, M.; Solari, A.; Bajetto, A.; Nista, F.; Campana, C.; Gaggero, G.; Prior, A.; Rossi, D. C.; Zona, G.; Ferone, D.; Florio, T.; Gatto, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly | 1-gen-2019 | Gatto, F.; Campana, C.; Cocchiara, F.; Corica, Giuliana; Albertelli, M.; Boschetti, M.; Zona, G.; Criminelli, D.; Giusti, M.; Ferone, D. | |
| Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients | 1-gen-2019 | Teti, C.; Talco, M.; Albertelli, M.; Albanese, V.; Minuto, M.; Aglialoro, A.; Monachesi, M.; Viviani, G.; Gatto, F.; Ferone, D.; Boschetti, M. | |
| Aggressive and malignant prolactinomas | 1-gen-2019 | Olarescu, Nicoleta; Perez-Rivas, Luis; Gatto, Federico; Cuny, Thomas; Tichomirowa, Maria; Tamagno, Gianluca; Gahete, Manuel | |
| Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression | 1-gen-2019 | Muhammad, Ammar; Coopmans, Eva. C.; Gatto, Federico; Franck, Sanne E.; Janssen, Joseph A. M. J. L.; Jan van der Lely, Aart; Hofland, Leo J.; Neggers, Sebastian J. C. M. M. | |
| Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells | 1-gen-2019 | Gatto, Federico; Arvigo, Marica; Amaru', Jessica; Campana, Claudia; Cocchiara, Francesco; Graziani, Giulia; Bruzzone, Eleonora; Giusti, Massimo; Boschetti, Mara; Ferone, Diego | |
| Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxide | 1-gen-2020 | Sileo, F.; Cangiano, B.; Cacciatore, C.; Amaru, J.; Gatto, F.; Albertelli, M.; Falconi, M.; Vitale, G.; Persani, L. | |
| Diagnosis and Treatment of Parasellar Lesions | 1-gen-2020 | Gatto, F; Perez-Rivas, Lg; Olarescu, Nc; Khandeva, P; Chachlaki, K; Trivellin, G; Gahete, Md; Cuny, T. | |
| Left ventricular mass reduction by a low-sodium diet in treated hypertensive patients | 1-gen-2020 | Musso, N.; Gatto, F.; Nista, F.; Dotto, A.; Shen, Z.; Ferone, D. | |
| Sodium Intake and Target Organ Damage in Hypertension-An Update about the Role of a Real Villain | 1-gen-2020 | Nista, Federica; Gatto, Federico; Albertelli, Manuela; Musso, Natale | |
| Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study. | 1-gen-2020 | Mazziotti, Gherardo; Battista, Claudia; Maffezzoni, Filippo; Chiloiro, Sabrina; Ferrante, Emanuele; Prencipe, Nunzia; Grasso, Ludovica; Gatto, Federico; Olivetti, Roberto; Arosio, Maura; Barale, Marco; Bianchi, Antonio; Cellini, Miriam; Chiodini, Iacopo; De Marinis, Laura; Del Sindaco, Giulia; Di Somma, Carolina; Ferlin, Alberto; Ghigo, Ezio; Giampietro, Antonella; Grottoli, Silvia; Lavezzi, Elisabetta; Mantovani, Giovanna; Morenghi, Emanuela; Pivonello, Rosario; Porcelli, Teresa; Procopio, Massimo; Pugliese, Flavia; Scillitani, Alfredo; Gerardo Lania, Andrea | |
| Somatostatin receptor expression and patients' response to targeted medical treatment in pituitary tumors: evidences and controversies. | 1-gen-2020 | Gatto, F; Arvigo, M; Ferone, D. | |
| Emerging drugs for the treatment of acromegaly | 1-gen-2020 | Campana, C.; Corica, G.; Nista, F.; Cocchiara, F.; Graziani, G.; Khorrami, K.; Franco, M.; Boschetti, M.; Ferone, D.; Gatto, F. | |
| β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids | 1-gen-2020 | Gatto, Federico; A Feelders, Richard; van der Pas, Rob; van Koetsveld, Peter; Bruzzone, Eleonora; Arvigo, Marica; Dogan, Fadime; Lamberts, Steven; Ferone, Diego; Hofland, L | |
| Octreotide-resistant acromegaly: Challenges and solutions | 1-gen-2020 | Corica, G.; Ceraudo, M.; Campana, C.; Nista, F.; Boschetti, M.; Zona, G.; Criminelli, D.; Ferone, D.; Gatto, F. | |
| Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients | 1-gen-2020 | Paolino, S; Gotelli, E; Goegan, F; Casabella, A; Ferrari, G; Patane, M; Albertelli, M; Gatto, F; Pizzorni, C; Cattelan, F; Sulli, A; Smith, V; Cutolo, M | |
| Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment | 1-gen-2021 | Campana, C.; Cocchiara, F.; Corica, G.; Nista, F.; Arvigo, M.; Amaru, J.; Rossi, D. C.; Zona, G.; Ferone, D.; Gatto, F. | |
| Acromegaly Management in a Tertiary Referral Center After 1 Year of the Coronavirus 2019 Pandemic: A Double Challenge | 1-gen-2021 | Gatto, F.; Khorrami, K.; Nista, F.; Corica, G.; Ferone, D. | |
| Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective | 1-gen-2021 | Nista, F.; Corica, G.; Castelletti, L.; Khorrami, K.; Campana, C.; Cocchiara, F.; Zoppoli, G.; Prior, A.; Rossi, D. C.; Zona, G.; Ferone, D.; Gatto, F. | |
| Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length | 1-gen-2021 | Cocchiara, Francesco; Campana, Claudia; Nista, Federica; Corica, Giuliana; Ceraudo, Marco; Milioto, Angelo; Criminelli Rossi, Diego; Zona, Gianluigi; Ferone, Diego; Gatto, Federico | |
| Octreotide and pasireotide combination treatment in somatotroph tumor cells: Predominant role of sst2 in mediating ligand effects | 1-gen-2021 | Amaru, J.; Barbieri, F.; Arvigo, M.; Solari, A.; Bajetto, A.; Nista, F.; Campana, C.; Gaggero, G.; Prior, A.; Rossi, D. C.; Zona, G.; Ferone, D.; Florio, T.; Gatto, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile